Breast cancer (BC) and severe COVID-19 (C-19) outcomes: a matched analysis.
Marija SullivanXiudong Jennifer LeiSharon H GiordanoMariana Chavez Mac GregorPublished in: Breast cancer research and treatment (2024)
Patients with BC have a similar risk of adverse C-19 outcomes compared to patients without cancer. Among patients with BC, recent chemotherapy was associated with a higher risk of hospitalization.
Keyphrases
- end stage renal disease
- coronavirus disease
- sars cov
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- squamous cell carcinoma
- type diabetes
- emergency department
- early onset
- squamous cell
- skeletal muscle
- locally advanced
- young adults
- adverse drug
- childhood cancer
- glycemic control
- respiratory syndrome coronavirus
- electronic health record